This study showed that a high MCPIP1 level decreased the phosphorylation of the c-Met receptor, Src kinase, and the transcription factor STAT3 in RCC cells, even after the acquisition of sunitinib and sorafenib resistance. The gene discussed is ZC3H12A; the disease is renal cell carcinoma.